AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Karyopharm Therapeutics Inc.

$0.66 -$6.53 (-90.79%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$0.88
Day Range
$0.60$0.88
Year Range
$0.31$10.99
Market Cap
15.02M
AVG Volume
2.3M
Trailing/Forward PE
-0.03/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-02
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KPTI Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2146.62M
26 Q1151.12M
25 Q4146.07M
25 Q3142.53M
25 Q2137.27M
25 Q1142.13M
24 Q4145.24M
24 Q3148.44M
24 Q2145.67M
24 Q1140.46M
Net Income (USD) · TTM
-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KPTI Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-224.74M
26 Q1-194.97M
25 Q4-196.04M
25 Q3-124.62M
25 Q2-123.57M
25 Q1-62.52M
24 Q4-76.42M
24 Q3-87.48M
24 Q2-89.91M
24 Q1-146.34M
Operating Income (USD) · TTM
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KPTI Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-82.35M
26 Q1-84.21M
25 Q4-90.71M
25 Q3-104.14M
25 Q2-115.21M
25 Q1-118.94M
24 Q4-119.44M
24 Q3-125.97M
24 Q2-130.95M
24 Q1-132.4M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: KPTI

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 2 Nov 2026.

Karyopharm Therapeutics Inc.
KPTI
Stockpicker

Video analysis: KPTI

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KPTI

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.